UBS Group
CRVS icon

UBS Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$359K Buy
89,714
+53,320
+147% +$213K ﹤0.01% 5087
2025
Q1
$116K Sell
36,394
-15,715
-30% -$50K ﹤0.01% 5676
2024
Q4
$279K Buy
52,109
+36,428
+232% +$195K ﹤0.01% 5058
2024
Q3
$82.8K Buy
15,681
+2,681
+21% +$14.2K ﹤0.01% 5292
2024
Q2
$23.7K Buy
13,000
+8,321
+178% +$15.1K ﹤0.01% 6046
2024
Q1
$8.33K Sell
4,679
-2,021
-30% -$3.6K ﹤0.01% 6164
2023
Q4
$11.8K Hold
6,700
﹤0.01% 6173
2023
Q3
$9.78K Hold
6,700
﹤0.01% 5982
2023
Q2
$15.3K Sell
6,700
-4,314
-39% -$9.88K ﹤0.01% 5915
2023
Q1
$10K Buy
11,014
+6,314
+134% +$5.75K ﹤0.01% 6520
2022
Q4
$4K Sell
4,700
-17,956
-79% -$15.3K ﹤0.01% 8208
2022
Q3
$18K Buy
22,656
+85
+0.4% +$68 ﹤0.01% 6418
2022
Q2
$22K Buy
22,571
+8,464
+60% +$8.25K ﹤0.01% 5716
2022
Q1
$23K Buy
14,107
+4,837
+52% +$7.89K ﹤0.01% 6243
2021
Q4
$22K Buy
9,270
+6,270
+209% +$14.9K ﹤0.01% 6604
2021
Q3
$15K Hold
3,000
﹤0.01% 6354
2021
Q2
$8K Hold
3,000
﹤0.01% 7126
2021
Q1
$9K Sell
3,000
-7,043
-70% -$21.1K ﹤0.01% 6967
2020
Q4
$36K Buy
10,043
+5,740
+133% +$20.6K ﹤0.01% 5474
2020
Q3
$17K Buy
4,303
+3,584
+498% +$14.2K ﹤0.01% 5567
2020
Q2
$2K Sell
719
-2,097
-74% -$5.83K ﹤0.01% 6758
2020
Q1
$6K Buy
+2,816
New +$6K ﹤0.01% 6293
2019
Q3
Sell
-17
Closed 7014
2019
Q2
$0 Sell
17
-5,508
-100% ﹤0.01% 6985
2019
Q1
$22K Sell
5,525
-867
-14% -$3.45K ﹤0.01% 5389
2018
Q4
$23K Buy
+6,392
New +$23K ﹤0.01% 5744
2018
Q2
Sell
-1,776
Closed -$20K 7033
2018
Q1
$20K Sell
1,776
-7,531
-81% -$84.8K ﹤0.01% 5536
2017
Q4
$96K Buy
9,307
+7,977
+600% +$82.3K ﹤0.01% 4446
2017
Q3
$21K Buy
+1,330
New +$21K ﹤0.01% 5505
2017
Q2
Sell
-698
Closed -$15K 6710
2017
Q1
$15K Sell
698
-662
-49% -$14.2K ﹤0.01% 5426
2016
Q4
$19K Buy
+1,360
New +$19K ﹤0.01% 5596
2016
Q3
Sell
-1,419
Closed -$20K 6709
2016
Q2
$20K Buy
+1,419
New +$20K ﹤0.01% 5425